Phase I trial of TT 601, which is being developed for the treatment of osteoarthritis.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2013
At a glance
- Drugs TT 601 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 25 Jul 2013 New trial record
- 23 Jul 2013 This trial is expected to be initiated in the first half of 2014, according to a Transition Therapeutics media release.